You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
24 September 2026 - GRAIL Inc, a healthcare company focused on early cancer detection,, announced on Wednesday a favourable vote from the Molecular and Clinical Genetics Devices Panel of the Medical Devices Advisory Committee of the US Food and Drug ...
24 September 2026 - Japanese pharmaceutical company Astellas Pharma Inc (TSE:4503) announced on Wednesday that the first patient has been dosed in a Phase 3 study evaluating setidegrasib, a novel, investigational KRAS G12D-targeted protein degrader, ...
23 September 2026 - Biopharmaceutical company AstraZeneca (LSE: AZN) (STO: AZN) (NYSE: AZN) declared on Wednesday that it has received European Commission approval for Trixeo Aerosphere as a maintenance treatment for asthma in patients aged 12 and ov...
23 September 2026 - RNA-targeted medicine company Ionis Pharmaceuticals Inc (Nasdaq: IONS) and healthcare company Roche on Wednesday reported positive interim results from the Phase 3 IMAgINATION study of investigational sefaxersen in adults with pri...
23 September 2026 - X-Chem, a US-based global company involved in innovative drug discovery services, announced on Tuesday the achievement of a milestone following Relay Therapeutics' initiation of a Phase 3 clinical trial of a drug candidate de...
23 September 2026 - BoomRay Pharmaceuticals Co., Ltd., a China-based clinical-stage biotechnology company involved in innovative radioligand therapies (RLTs) for precision oncology diagnostics and therapeutics, announced on Tuesday that it has entere...
22 September 2026 - US biopharmaceutical company AbbVie (NYSE: ABBV) said on Tuesday it has received European Commission approval for RINVOQ (upadacitinib) to treat active polyarticular juvenile idiopathic arthritis in patients aged two years and old...